Primary Care, Guidance

Applied filters

Care Setting (43)
- Adults (7)
- Care homes (10)
- Care of the elderly (1)
- Community Health Services (17)
- Dentistry (4)
- Health and Justice (14)
- Occupational Health (3)
- Paediatrics (1)
- Palliative and End of Life Care (2)
- Primary Care (43)
- Transfer of care (9)
- Trusts (17)
Guidance (43)
- Adherence (1)
- Administering (8)
- Adverse effects (3)
- Cautions and contraindications (1)
- Complementary medicines (3)
- Dosing (1)
- Formulation (1)
- Implementation (2)
- Interactions (3)
- Medication Safety (2)
- Patient Group Directions (13)
- Poisoning (1)
- Policy, Commissioning and Managerial (3)
- Prescribing (2)
- Safety in Breastfeeding (1)
- Safety in Pregnancy (1)
- Service advice and planning (5)
- Supply (7)
- Swallowing difficulties (3)
- Switching (4)
- Temperature management (1)
  - Cold chain management (1)
- Unlicensed medicines (1)
Medicine (14)
- Adrenaline (2)
- Agomelatine (1)
- Alendronic acid (1)
- Amantadine (1)
- Amitriptyline (1)
- Amoxicillin (1)
- Articaine + Adrenaline (1)
- Atorvastatin (1)
- Beclometasone (1)
- Beclometasone + Formoterol (1)
- Bromocriptine (1)
- Budesonide (1)
- Budesonide + Formoterol (1)
- Buprenorphine (1)
- COVID-19 vaccine (1)
- Cabergoline (1)
- Carbamazepine (2)
- Carbidopa + Levodopa + Entacapone (2)
- Cholesterol + Simvastatin (1)
- Ciclosporin (1)
- Citalopram (1)
- Clozapine (1)
- Co-beneldopa (1)
- Co-careldopa (1)
- Diltiazem (1)
- Doxazosin (1)
- Doxepin (1)
- Duloxetine (1)
- Entacapone (1)
- Escitalopram (1)
- Fentanyl (1)
- Fluoxetine (1)
- Fluticasone (1)
- Fluticasone + Formoterol (1)
- Fluticasone + Salmeterol (1)
- Fluvastatin (1)
- Fluvoxamine (1)
- Ibandronic acid (1)
- Imipramine (1)
- Influenza vaccine (1)
- Isocarboxazid (1)
- Levodopa (1)
- Levodopa + Carbidopa + Entacapone (2)
- Levothyroxine (1)
- Lidocaine (1)
- Lidocaine + Adrenaline (1)
- Lidocaine + Prilocaine (1)
- Lithium (1)
- Lithium carbonate (1)
- Lofepramine (1)
- Lovastatin (1)
- Mepivacaine (1)
- Mepivacaine + Adrenaline (1)
- Mesalazine (1)
- Methotrexate (2)
- Methylphenidate (1)
- Mianserin (1)
- Mirtazapine (1)
- Moclobemide (1)
- Morphine (1)
- Mycophenolate mofetil (1)
- Nifedipine (1)
- Nortriptyline (1)
- Oseltamivir (1)
- Oxycodone (1)
- Paroxetine (1)
- Pergolide (1)
- Phenelzine (1)
- Phenobarbital (1)
- Phenoxymethylpenicillin (1)
- Phenytoin (2)
- Pramipexole (1)
- Pravastatin (1)
- Prilocaine (1)
- Prilocaine + Felypressin (1)
- Primidone (1)
- Rasagiline (1)
- Reboxetine (1)
- Risedronate sodium (1)
- Ropinirole (1)
- Rosuvastatin (1)
- Rotigotine (1)
- Selegiline (2)
- Sertraline (1)
- Simvastatin (1)
- Sodium valproate (1)
- Tacrolimus (1)
- Tiotropium (1)
- Tolcapone (1)
- Tramadol (1)
- Tranylcypromine (1)
- Trimipramine (1)
- Venlafaxine (1)
- Vortioxetine (1)
- Warfarin (1)
Medicines planning (4)
- Patient Group Direction Planning (4)
Publications (3)
- Research and audits (1)
- Summary advice (1)
- Templates (1)
Specialty (8)
- Cardiovascular system disorders (2)
- Diabetes (1)
- Endocrine system disorders (1)
- Mental health and illness (2)
- Neurological disorders (3)
- Reproductive health (1)
- Vaccinating (1)
Training and Development (6)

The Use of Generic Anti Epileptics Drugs in Patients with Epilepsy

28 September 2020Consensus views of the Pharmaceutical Market Support Group and the UK Clinical Pharmacists Association: Neurosciences Group on the safety and appropriateness of switching between brand…

Transcribing in the patient's home with healthcare input

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in the patient's home with healthcare input

Understanding transcribing for medicines administration

22 February 2022Transcribing for medicines administration in healthcare requires assessment and mitigation against identified risks. These risks vary according to setting.

Using Standardised Strengths of Unlicensed Liquid Medicines in Children

10 October 2019A joint statement from the Neonatal and Paediatric Pharmacy Group (NPPG) and the Royal College of Paediatrics and Child Health (RCPCH)

Using coenzyme Q10 supplements for statin-induced muscle symptoms

18 February 2022People often buy coenzyme Q10 supplements to help with statin-induced muscle symptoms. However, there is insufficient evidence to recommend its use.

Using medicines under PGD as part of a clinical trial or study

26 June 2019Advice on the use of Patient Group Directions (PGDs) to supply or administer a medication which is part of a clinical trial, study or pilot

Using oseltamivir under PGD for care home residents

8 September 2020A summary of when and how a Patient Group Direction (PGD) may be legally used to supply and/or administer oral oseltamivir to care home residents

Using written instructions for seasonal ‘flu vaccination

25 August 2021Advice on using written instructions for the administration of 'flu vaccinations to healthcare staff.

What is the clinical significance of potential drug interactions with local anaesthetic preparations used in primary care dentistry?

30 July 2020This updated Medicines Q&A explores the clinical significance of potential interactions between dental local anaesthetic preparations and other medicines as listed in the BNF and…

What is the clinical significance of the interaction between methotrexate and penicillins?

1 October 2020The evidence for an interaction between methotrexate and penicillins is limited to case reports and animal studies. So far, there is no conclusive evidence that…

SPS - Specialist Pharmacy Service

NHS